Last reviewed · How we verify
DDP synchronous with radiotherapy
DDP synchronous with radiotherapy is a Platinum-based chemotherapy Small molecule drug developed by Yong Zhang,MD. It is currently in Phase 2 development for Synchronous with radiotherapy for various cancers. Also known as: Cisplatin.
DDP is a chemotherapy drug that works by interfering with DNA replication, making it difficult for cancer cells to divide and grow.
DDP is a chemotherapy drug that works by interfering with DNA replication, making it difficult for cancer cells to divide and grow. Used for Synchronous with radiotherapy for various cancers.
At a glance
| Generic name | DDP synchronous with radiotherapy |
|---|---|
| Also known as | Cisplatin |
| Sponsor | Yong Zhang,MD |
| Drug class | Platinum-based chemotherapy |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 2 |
Mechanism of action
DDP, or cisplatin, is a platinum-based chemotherapy drug that forms platinum-DNA adducts, which prevent DNA replication and transcription, ultimately leading to cell death. This mechanism is particularly effective in rapidly dividing cancer cells.
Approved indications
- Synchronous with radiotherapy for various cancers
Common side effects
- Nausea and vomiting
- Neutropenia
- Anemia
- Thrombocytopenia
- Kidney damage
Key clinical trials
- Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma (PHASE3)
- A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC) (PHASE2)
- Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) (PHASE3)
- Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DDP synchronous with radiotherapy CI brief — competitive landscape report
- DDP synchronous with radiotherapy updates RSS · CI watch RSS
- Yong Zhang,MD portfolio CI
Frequently asked questions about DDP synchronous with radiotherapy
What is DDP synchronous with radiotherapy?
How does DDP synchronous with radiotherapy work?
What is DDP synchronous with radiotherapy used for?
Who makes DDP synchronous with radiotherapy?
Is DDP synchronous with radiotherapy also known as anything else?
What drug class is DDP synchronous with radiotherapy in?
What development phase is DDP synchronous with radiotherapy in?
What are the side effects of DDP synchronous with radiotherapy?
Related
- Drug class: All Platinum-based chemotherapy drugs
- Manufacturer: Yong Zhang,MD — full pipeline
- Therapeutic area: All drugs in Oncology
- Indication: Drugs for Synchronous with radiotherapy for various cancers
- Also known as: Cisplatin
- Compare: DDP synchronous with radiotherapy vs similar drugs
- Pricing: DDP synchronous with radiotherapy cost, discount & access